The latest news in BBVA Switzerland

The latest BBVA podcasts you may not miss: February 2021

Stay up to date from anywhere with the 5 podcasts we recommend this February.

Webinar Private Equity Vision 2021

BBVA in Switzerland organized a webinar on Private Equity on February 10th. The webinar was broadcasted live through its own Youtube channel. On this occasion the experts in Third Party Products, David Requena and Maria Arroyo, analyze the situation of Private Equity in the current environment and investment strategies for this year 2021.

Weekly Key: What is happening this week? 22.02.2021

Coronavirus cases worldwide decrease significantly as vaccination campaigns progress. Markets react with slight stock market declines and yield rallies.

Investment Strategy 2021

BBVA in Switzerland organized a webinar on Investment Strategies 2021. The webinar was broadcasted live on the bank's Youtube profile. Experts from BBVA's Investment and Markets team in Switzerland analyze the situation in the current environment, selecting the best investment ideas and strategies for 2021.

Humans and robots increase business productivity when they work together

Greater business productivity is achieved when robots are programmed to work in tandem with humans, rather than replacing them.

Weekly Keys: What is happening this week? 01.02.2021

The week was marked by the volatility of certain stocks driven by the association of minority shareholders and the mandatory short covering of several hedge funds.

Investing in health technologies to prevent cancer

According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, reaching 9.6 million deaths in 2018. According to WHO forecasts, cancer deaths will increase worldwide until 2030, from 8 to 13 million annually. The oncology market will be driven by productive R&D (research and development). Different vehicles, such as investment funds or ETFs, give investors the possibility to support medical research and, in doing so, join the fight against cancer by generating an impact investment, with a common long term objective.